Introduction
In a significant strategic shift in the health media landscape, Central Medience Co., Ltd. has officially announced the transfer of its health media business,
Karada ni Ii Koto, to GENOVA Inc., effective September 14, 2026. This transition represents not just a shift in ownership but a strategic enhancement in the quality and reliability of healthcare content being produced for consumers.
Details of the Business Transfer
Central Medience, headquartered in Minato, Tokyo, will pass on the operational reins of
Karada ni Ii Koto, a well-regarded health media platform, to GENOVA, a company that also operates a medical media platform called
Medical DOC. This transfer will enrich GENOVA’s resources, allowing them to leverage the knowledge and expertise developed through
Karada ni Ii Koto to strengthen their existing medical information services.
GENOVA has made it clear that they are committed to building a healthcare infrastructure suitable for the 21st century, linking patients and medical services as part of their core mission. Their established network within medical institutions positions them well to integrate valuable information derived from both platforms to enhance public health communications.
Purpose of the Transfer
GENOVA envisions utilizing the established framework of
Karada ni Ii Koto to broaden their output of reliable and high-quality healthcare content across various platforms, both online and offline. This business transfer is expected to significantly enhance the credibility and reach of their medical information dissemination. The mission of GENOVA, 'Connecting People and Healthcare to Create a Healthy Society', aligns with the strategic objectives of this transfer, aiming to create a seamless link between traditional healthcare services and digital solutions.
Future Prospects and Synergies
The fusion of
Karada ni Ii Koto’s strengths with GENOVA’s existing capabilities in medical content creation will facilitate the development of new, engaging healthcare information tailored for modern audiences. The integration of content creation efforts will also see a collaborative approach in service delivery across various platforms, enabling businesses and healthcare providers to better connect with the needs of the consumers.
GENOVA’s strategic goals, laid out in their
VISION 2026 initiative, call for a blended approach involving both real-world and digital interactions in the health sector. Through the strengthened capabilities of
Medical DOC and the now-included insights from
Karada ni Ii Koto, they aspire to build unshakeable trust between patients and healthcare providers, which is pivotal for the future of Japan’s healthcare infrastructure.
About GENOVA
Established with a mission focused on the improvement of healthcare connectivity, GENOVA stands at the forefront of innovative healthcare technology services. The company is dedicated to addressing pressing societal issues such as the shortage of healthcare professionals in Japan, which is exacerbated by the aging population, and the expansion of national healthcare expenses. Through their expansive portfolio, GENOVA aims to alleviate the anxieties and challenges faced by patients, ensuring more efficient and quality healthcare experiences.
Company Overview
- - Company Name: GENOVA Inc.
- - Headquarters: Shibuya, Tokyo, Japan
- - Business Areas: Medical platform services, smart clinic services, dental distribution services
- - Website: GENOVA Corporate Site
About Central Medience
Founded in 2018, Central Medience limited aims to innovate healthcare services aligned with contemporary needs. They emphasize the pivotal shift from traditional healthcare services to proactive preventive measures. Their operations center around optimizing healthcare facilities while contributing to societal advancement through effective medical support solutions.
Company Overview
- - Company Name: Central Medience Co., Ltd.
- - Headquarters: Minato, Tokyo, Japan
- - Business Areas: Medical consulting, pharmaceutical wholesale, human resources, and finance services
- - Website: Central Medience Corporate Site
Conclusion
The transfer of
Karada ni Ii Koto marks a proactive step into the future where both companies intend to collaborate toward elevating healthcare content, making credible medical information more accessible to the public. The anticipated synergies between Central Medience and GENOVA, particularly in the fields of content creation and healthcare communication, herald a promising new chapter in health media.